Head-to-head · Cost-Efficiency Index
Mochi Health vs Call-On-Doc
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Mochi Health
Shoppers who want obesity-medicine physician access bundled with the prescription, and don't mind two separate line items.
Visit Mochi HealthCall-On-Doc
Shoppers who already have insurance covering a branded GLP-1 and want a low-cost consult subscription to get the prescription written.
Visit Call-On-DocThe verdict
Mochi Health takes it, leading the Cost-Efficiency Index 56 to 55. Mochi Health is a San Francisco-based telehealth platform bundling compounded GLP-1 prescriptions with a required $79/mo membership (obesity-medicine physician access, in-app coaching), available in all 50 states. Call-On-Doc still earns a C — Shoppers who already have insurance covering a branded GLP-1 and want a low-cost consult subscription to get the prescription written.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Mochi Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Mochi Health | Call-On-Doc |
|---|---|---|
| Cost-Efficiency Index | 56/100 | 55/100 |
| Semaglutide / mo | $178/mo (starting dose, plus a separate fee, compounded) | Not disclosed |
| Tirzepatide / mo | $278/mo (starting dose, plus a separate fee, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $2,136 | — |
| Tirzepatide / yr (modeled) | $3,336 | — |
| Coverage | 15 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #330 | #336 |
Mochi Health
56/100Where the value is
- Names five board-certified obesity-medicine physicians on its About page (Valledor, Jones, Barrick, A. Patel, Am. Patel MDs/DOs), unusual specificity for this tier of provider
- Available in all 50 states per the About page, a real expansion from the network dataset's outdated '15 states'
- Membership includes ongoing care-team messaging and coaching, not just a one-time prescription
The tradeoffs
- The advertised '$99' and '$199' medication prices are NOT the monthly cost — a separate $79/mo membership is mandatory and stacks on top, so the real floor is $178/mo (semaglutide) and $278/mo (tirzepatide)
- No compounding pharmacy is named anywhere on the site, including a dedicated /pharmacy page that markets the partnership program without ever identifying a partner
Call-On-Doc
55/100Where the value is
- LegitScript seal displayed, with 50-state coverage claimed via a state-selection dropdown
- Low-cost visit subscription tiers ($24.99-$49.99/mo) that include multiple free visits per month, cheaper than most one-off telehealth consult fees
- Explicitly lets patients use their own insurance at their own pharmacy, which can be dramatically cheaper than a self-pay compounded-GLP-1 subscription for insured patients
The tradeoffs
- No fixed medication price exists anywhere on the site — actual drug cost depends entirely on the patient's own insurance and pharmacy, so it cannot be compared apples-to-apples against competitors with a published price
- Uninsured or underinsured patients could pay full retail branded-drug price (often $1,000+/month) with no compounded fallback offered here
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.